Advertisement
YOU ARE HERE: LAT HomeCollectionsInc Pharmaceuticals Inc
IN THE NEWS

Inc Pharmaceuticals Inc

FEATURED ARTICLES
BUSINESS
August 17, 2001 | From Bloomberg News
ICN Pharmaceuticals Inc.'s ribavirin drug, used in combination with a Schering-Plough Corp. drug to treat hepatitis C, may face generic competition within a year if an unidentified company wins Food and Drug Administration approval for its version. The FDA's Web site said the agency has received a request from a company to sell a generic version of ribavirin, which is sold by Schering-Plough with its own hepatitis C drugs Intron A and Peg-Intron.
ARTICLES BY DATE
BUSINESS
August 17, 2001 | From Bloomberg News
ICN Pharmaceuticals Inc.'s ribavirin drug, used in combination with a Schering-Plough Corp. drug to treat hepatitis C, may face generic competition within a year if an unidentified company wins Food and Drug Administration approval for its version. The FDA's Web site said the agency has received a request from a company to sell a generic version of ribavirin, which is sold by Schering-Plough with its own hepatitis C drugs Intron A and Peg-Intron.
Advertisement
BUSINESS
July 13, 2005 | From Bloomberg News
Pharmacopeia Drug Discovery Inc. said it would work with Allergan Inc. to develop treatments for a leading cause of blindness that might compete with drugs from Pfizer Inc., Eyetech Pharmaceuticals Inc. and Genentech Inc. Pharmacopeia and Allergan, maker of the Botox wrinkle treatment, said they would collaborate on drugs for age-related degeneration of the eye's macula.
BUSINESS
October 3, 2001
* The Defense Department said it probably will decide this week whether to approve bids from General Dynamics Corp. or Northrop Grumman Corp. for rival defense contractor Newport News Shipbuilding Inc. The Pentagon said it plans to forward its decision to the Justice Department after hearing from the companies one more time.
BUSINESS
February 3, 2004 | From Associated Press
Gene-hunting pioneer Incyte Corp. announced Monday that it would lay off more than half its staff and close a gene-collection office, completing its transition out of the once red-hot field of genomics. The company said its proprietary database of human genes could no longer compete now that detailed genetic codes are available free via the Internet.
BUSINESS
July 10, 1997 | (Bloomberg News)
Drug companies that make and sell two products widely used in combination as a weight-loss treatment were sued after a Mayo Clinic report linked the treatment to serious cardiovascular health risks. The suit, filed in U.S. District Court in San Francisco, names American Home Products Corp., SmithKline Beecham Inc., Medeva Pharmaceuticals Inc. and Richwood Pharmaceuticals Co., among others.
BUSINESS
July 3, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
ICN Pharmaceuticals Inc., the company that Yugoslav immigrant Milan Panic built from scratch, is well-positioned to benefit financially from its founder's announcement Thursday that he will accept the post of prime minister for his troubled homeland, financial analysts said. But depending on who is talking, the reasons vary widely.
BUSINESS
May 15, 2001 | Bloomberg News
Shares of EntreMed Inc., OSI Pharmaceuticals Inc. and ImmunoGen Inc. tumbled Monday after the biotechnology companies presented research showing smaller benefits than investors hoped to see from their experimental cancer drugs. The companies provided the results over the weekend at the American Society of Clinical Oncology, the most closely watched cancer research meeting of the year. EntreMed (ticker symbol: ENMD) fell $3.95, or 21%, to $15.30 on Monday. OSI fell (OSIP) $3.33, or 7.7%, to $40.
BUSINESS
September 2, 1998 | LESLIE EARNEST and JOHN O'DELL, TIMES STAFF WRITERS
Orange County stocks recovered some of their heavy losses Tuesday, led by companies that absorbed some of the biggest hits during Monday's big market sell-off. What a difference a day made for Consumer Portfolio Services Inc. shares, which surged 51% to rank second on the list of percentage gainers in the county.
Los Angeles Times Articles
|